Literature DB >> 20374320

Lest we forget Hansen's disease (leprosy): an unusual presentation with an acute onset of inflammatory polyarthritis and the rheumatology experience.

Salvi Sheetal1, Chopra Arvind.   

Abstract

Several forms of arthritis and rheumatism can sometimes complicate leprosy. However, its presentation as an acute onset arthritis is unusual. We report two adult male naïve patients who presented to our rheumatology outpatient clinic with acute onset inflammatory polyarthritis, skin rash and mild sensory neurodeficit. Borderline lepromatous leprosy (in type I lepra reaction) was diagnosed. We also refer to 19 case records of Hansen arthritis in the clinic database (1998-2007) from approximately 35,000 patients and a community study to highlight the missed diagnosis of Hansen's disease and its unusual association with rheumatoid arthritis. In countries like India where leprosy is endemic, this disease also merits attention in rheumatology clinics.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20374320     DOI: 10.1111/j.1756-185X.2009.01382.x

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  4 in total

1.  Hansen's Disease and Rheumatoid Arthritis Crossover of Clinical Symptoms: A Case Series of 18 Patients in the United States.

Authors:  Sarah M Labuda; John S Schieffelin; Jeffrey G Shaffer; Barbara M Stryjewska
Journal:  Am J Trop Med Hyg       Date:  2017-10-19       Impact factor: 2.345

2.  Leprosy with ANA positive mistaken for connective tissue disease.

Authors:  Guanqun Chao; Lizheng Fang; Chongrong Lu
Journal:  Clin Rheumatol       Date:  2013-02-05       Impact factor: 2.980

3.  Recurrent ulcers: a diagnostic challenge.

Authors:  Mary Thomas; Jp Pratibha; Margery Emmanuel; Aruno Nakhro Neivitro
Journal:  Indian J Dermatol       Date:  2013-07       Impact factor: 1.494

Review 4.  Leprosy in a rheumatology setting: a challenging mimic to expose.

Authors:  Sheetal Salvi; Arvind Chopra
Journal:  Clin Rheumatol       Date:  2013-05-07       Impact factor: 2.980

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.